Menu
Montecito
American Riviera
Loading...
You are here:  Home  >  'Amgen'  -  Page 33
Latest

Amgen laying off 121 workers in Thousand Oaks

By   /  Friday, November 10th, 2017  /  Central Coast Health Watch, East Ventura County, Latest news, Technology, Tri-County Economy, Tri-County Public Companies  /  Comments Off on Amgen laying off 121 workers in Thousand Oaks

This article is only available to Business Times subscribers Subscribers: LOG IN or REGISTER for complete digital access. Not a Subscriber? SUBSCRIBE for full access to our weekly newspaper, online edition and Book of Lists. Check the STATUS of your Subscription Account.

Read More →
Latest

Our view: Federal tax ‘reform’ plan targets high tax states

By   /  Friday, November 10th, 2017  /  Editorials, Latest news, Opinion  /  Comments Off on Our view: Federal tax ‘reform’ plan targets high tax states

This article is only available to Business Times subscribers Subscribers: LOG IN or REGISTER for complete digital access. Not a Subscriber? SUBSCRIBE for full access to our weekly newspaper, online edition and Book of Lists. Check the STATUS of your Subscription Account.

Read More →
Latest

Wanted: 700 workers for tri-county tech jobs

By   /  Friday, November 10th, 2017  /  Central Coast, Latest news, Technology, Tri-County Economy  /  Comments Off on Wanted: 700 workers for tri-county tech jobs

This article is only available to Business Times subscribers Subscribers: LOG IN or REGISTER for complete digital access. Not a Subscriber? SUBSCRIBE for full access to our weekly newspaper, online edition and Book of Lists. Check the STATUS of your Subscription Account.

Read More →
Latest

Amgen launches second trial for Alzheimer’s product

By   /  Thursday, November 2nd, 2017  /  Central Coast Health Watch, Latest news  /  Comments Off on Amgen launches second trial for Alzheimer’s product

Amgen and Novartis launched a second trial for a product intended to delay or prevent Alzheimer’s disease, in partnership with the Banner Alzheimer’s Institute. The biotech giant based in Thousand Oaks had previously collaborated on the first study in the Alzhiemer’s Prevention Initiative Generation program, which enrolled participants who had two copies of the apolipoprotein Read More →

Read More →
Latest

Amgen buying out joint venture Kirin-Amgen for $780 million

By   /  Tuesday, October 31st, 2017  /  Central Coast Health Watch, Latest news, Technology  /  Comments Off on Amgen buying out joint venture Kirin-Amgen for $780 million

Amgen, the biotech giant based in Thousand Oaks, announced that it would buy out joint venture Kirin-Amgen, which was created to develop white blood cell booster Neupogen among other projects, for $780 million. The joint venture holds intellectual property rights for Neupogen, Neulasta, Aranesp, Nplate and brodalumab. In addition to the cash deal, Amgen will Read More →

Read More →
Latest

Amgen product sales slip but income stays steady

By   /  Thursday, October 26th, 2017  /  Central Coast Health Watch, East Ventura County, Latest news, Tri-County Economy, Tri-County Public Companies  /  Comments Off on Amgen product sales slip but income stays steady

Net income at biotech giant Amgen stayed flat for the third quarter, despite a slight downtick in revenues to $5.8 billion, the company reported Oct. 25. Product sales saw a slight decline, including Neupogen, Epogen and its blockbuster rheumatoid arthritis drug Enbrel, which fell 6 percent, but net income stayed steady at a little more Read More →

Read More →
Latest

Biotech giant Amgen to pay dividend on Dec. 8

By   /  Tuesday, October 24th, 2017  /  Central Coast Health Watch, Earnings, Latest news, Technology, Tri-County Public Companies  /  Comments Off on Biotech giant Amgen to pay dividend on Dec. 8

Biotech giant Amgen announced Oct. 24 that it would pay a $1.15 dividend for its fourth quarter of fiscal 2017. Stockholders of record for the Thousand Oaks-based company at the end of day on Nov. 17 will receive the dividend on Dec. 8.

Read More →